Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_187433765

Obesity leads to larger, harder-to-detect tumours in breast cancer, study finds

November 21, 2017
Manufacturing and Production, Research and Development Cancer, breast cancer, pharma

A study from Sweden’s Karolinska Institute has indicated that cancerous tumours in overweight women are likely to be larger and …

News
nhs_trees_brett_wells_source_web

NHS faced with 5,700% increase in drug price, finds CMA

November 21, 2017
Manufacturing and Production, Medical Communications CMA, Concordia, biotech, drugs, pharma, pharmaceutical

The Competition and Markets Authority (CMA) has pulled up Concordia as, provisionally, being found to have raised the price of …

News

And the winner is…Amsterdam takes EMA HQ

November 21, 2017
Manufacturing and Production, Medical Communications biotech, drugs, pharma, pharmaceutical

In a decision that was likened to a penalty shoot-out, Amsterdam was announced as the winner of the race to …

News
shutterstock_273326141

Partnerships hold the key to making HIV history

November 20, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Janssen, pharma

Brian Woodfall, Global Head of Late Development, Infectious Diseases at Janssen, explains why a future without HIV can only be …

Feature
acorda-therapeutics-inc-logo

Acorda scraps Parkinson’s drug after five trial deaths

November 20, 2017
Research and Development, Sales and Marketing Acorda therapeutics, Parkinson's, patient deaths, pharma

Acorda Therapeutics has announced that it is terminate development of its Parkinson’s therapy tozadenant after five deaths were reported as …

News
shutterstock_95714119

Children are still prescribed codeine despite FDA warnings, study finds

November 20, 2017
Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma

A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …

News

Roche unveils strong combination treatment data in lung cancer

November 20, 2017
Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …

News

Novartis’s Tasigna scores EU approval in paediatric patients

November 20, 2017
Sales and Marketing Europe, Novartis, Tasigna, chronic myeloid leukaemia, pharma

Novartis’s Tasigna (nilotinib) has received European Commission approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in …

News
samsung_bioepis

Samsung Bioepis’ Ontruzant becomes first Herceptin biosimilar approved in Europe

November 20, 2017
Sales and Marketing EMA, Herceptin, Roche, Samsung Bioepis

Samsung Bioepis has announced that Ontruzant, the company’s biosimilar version of Roche’s Herceptin, has been awarded marketing authorisation in Europe …

News
care_old

UK austerity measures to social care led to 120,000 deaths

November 17, 2017
Medical Communications UK, austerity, biotech, drugs, pharma, pharmaceutical, social care

A new study has claimed that austerity measures introduced since 2010 are linked to 120,000 deaths across England. The research …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile, top ten

It’s Friday, and it’s time for another rundown of our most popular articles with our readers this week. Besides a …

News
pfizer-building-logo1web

FDA expands use of Pfizer’s Sutent in kidney cancer

November 17, 2017
Medical Communications, Sales and Marketing Cancer, Kidney cancer, Pfizer, Sutent, pharma

Pfizer has announced that the FDA has expanded the use of its tyrosine kinase inhibitor Sutent (sunitinib malate) to include …

News

Roche’s haemophillia A treatment gets nod but with black box warning

November 17, 2017
Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical

Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …

News
boots

Boots under fire from Labour MPs over broken contraceptive promise

November 17, 2017
Medical Communications, Sales and Marketing Boots, biotech, drugs, morning after pill, pharma, pharmaceutical

Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …

News
alex_azar

Trump nominates Ex-Lilly exec for health secretary role

November 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …

Appointment
stem-cell-163711_640

Stem cell therapy fails to improve symptoms of peripheral artery disease

November 16, 2017
Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …

News
nss-2_device

FDA approves electronic nerve stimulator for opioid withdrawal

November 16, 2017
Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical

A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …

News

GSK gets EU go-ahead for triple therapy inhaler in COPD

November 16, 2017
Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …

News

NICE approves Novartis and Pfizer’s rival breast cancer drugs

November 16, 2017
Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical

NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …

News
arvinas-0004168-2

Genentech cements relationship with Arvinas with $650m deal

November 16, 2017
Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026